Anavex Life Sciences Corp (AVXL)

[LBSR TO DA MOON]

FWIW - News regarding ANVS:

Annovis Bio Completes Enrollment in Late-Stage Study of Buntanetap for Parkinson's Disease
MT NEWSWIRES 9:42 AM ET 6/8/2023
Symbol Last Price Change
ANVS 14.29down +0.31 (+2.2175%)
QUOTES AS OF 09:43:04 AM ET 06/08/2023
09:42 AM EDT, 06/08/2023 (MT Newswires) -- Annovis Bio(ANVS) said Thursday that it has completed the enrollment for its phase 3 study of its lead compound buntanetap, which is intended for the treatment of Parkinson's disease, a type of brain disorder.
The clinical-stage drug platform company said that, since the first patient was dosed in late August, more than 640 patients have been screened and 520 patients have been enrolled "in record time" across 67 sites.
The study is a placebo-controlled trial evaluating the drug candidate for early Parkinson's disease patients on top of their standard of care. The study is set to conclude in November, with topline assessment results available by the end of the year, the company said.
Shares of Annovis Bio(ANVS) added more than 2% in recent trading activity on Thursday.
Price: 14.35, Change: +0.37, Percent Change: +2.65
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.